Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells.
Natural T regulatory cells (Tregs) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. All trans retinoic acid (ATRA) plays an important role in mediating immune homeostasis in vivo, and we investigated whether ATRA could be used to promote the ex vivo expansion of Tregs purified from adult human peripheral blood. We found that ATRA helped maintain FOXP3 expression during the expansion process, but this effect was transient and serum-dependent. Furthermore, natural Tregs treated with rapamycin, but not with ATRA, suppressed cytokine production in co-cultured effector T cells. This suppressive activity correlated with the ability of expanded Tregs to induce FOXP3 expression in non-Treg cell populations. Examination of CD45RA+ and CD45RA- Treg subsets revealed that ATRA failed to maintain suppressive activity in either population, but interestingly, Tregs expanded in the presence of both rapamycin and ATRA displayed more suppressive activity and had a more favorable epigenetic status of the FOXP3 gene than Tregs expanded in the presence of rapamycin only. We conclude that while the use of ATRA as a single agent to expand Tregs for human therapy is not warranted, its use in combination with rapamycin may have benefit.
Department of Pathology and Laboratory Medicine and Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Tatiana N
TN
Golovina
Tatiana
T
Mikheeva
Todd M
TM
Brusko
Bruce R
BR
Blazar
Jeffrey A
JA
Bluestone
James L
JL
Riley
D018929:Cell Culture Techniques / Q000379:methods; D049109:Cell Proliferation / Q000187:drug effects*; D018920:Coculture Techniques; D016207:Cytokines / Q000096:biosynthesis; D004357:Drug Synergism; D051858:Forkhead Transcription Factors / Q000032:analysis; D006801:Humans; D020123:Sirolimus / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000166:cytology* / Q000187:drug effects; D014212:Tretinoin / Q000494:pharmacology*
D016207:Cytokines; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D014212:Tretinoin; D020123:Sirolimus
Eur J Immunol. 2007 Sep;37(9):2396-9
17694576
J Immunol. 2007 Sep 15;179(6):3724-33
17785809
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1903-8
19174509
Cell. 2000 May 26;101(5):455-8
10850488
J Immunol. 2008 Dec 15;181(12):8209-13
19050237
J Exp Med. 2007 Aug 6;204(8):1765-74
17620363
Blood. 2007 Oct 15;110(8):2983-90
17644734
Endocrinology. 1997 Feb;138(2):657-66
9003000
Nat Rev Immunol. 2003 Mar;3(3):253-7
12658273
Immunity. 2009 Jun 19;30(6):899-911
19464196
Transplantation. 2005 May 27;79(10):1310-6
15912097
J Immunol. 2008 May 1;180(9):5794-8
18424697
J Immunol. 2008 Aug 15;181(4):2277-84
18684916
Blood. 2006 Dec 15;108(13):4260-7
16917003
Nat Immunol. 2009 Sep;10(9):1000-7
19633673
Clin Dev Immunol. 2008;2008:416910
18389070
Nature. 2009 Jul 2;460(7251):108-12
19543266
Cancer Res. 2009 Jan 15;69(2):599-608
19147574
Immunity. 2008 Jul 18;29(1):44-56
18585065
Immunity. 2009 May;30(5):626-35
19464985
J Immunol. 2008 Mar 1;180(5):2830-8
18292504
Immunity. 2009 May;30(5):656-65
19464988
J Exp Med. 2007 Aug 6;204(8):1775-85
17620362
Science. 1993 Feb 12;259(5097):974-7
8094901
J Exp Med. 2005 Jan 17;201(2):259-66
15642745
Microbes Infect. 2009 Apr;11(5):594-8
19371792
PLoS Biol. 2007 Feb;5(2):e38
17298177
Immunity. 2008 Jun;28(6):870-80
18513999
J Immunol. 2008 Aug 15;181(4):2855-68
18684977
Blood. 2005 Jun 15;105(12):4743-8
15746082
Blood. 2009 Oct 29;114(18):3727-35
19641188
J Nutr. 2002 Sep;132(9):2743-7
12221239
Mol Ther. 2007 May;15(5):981-8
17375070
J Immunol. 2009 Sep 15;183(6):4119-26
19717521
J Clin Invest. 2008 Jan;118(1):294-305
18060041
J Immunol. 1995 Jan 1;154(1):450-8
7527821
J Exp Med. 2002 Aug 5;196(3):389-99
12163567
J Nutr. 2007 May;137(5):1216-21
17449584
Transplant Proc. 2009 Jul-Aug;41(6):2670-2
19715998
J Immunol. 2004 May 1;172(9):5213-21
15100259
Eur J Immunol. 2009 Nov;39(11):3091-6
19750478
Science. 2007 Jul 13;317(5835):256-60
17569825
J Exp Med. 2009 Feb 16;206(2):343-57
19204112
J Immunol. 2006 Dec 15;177(12):8338-47
17142730
J Exp Med. 2007 Aug 6;204(8):1757-64
17620361
Eur J Immunol. 2007 Sep;37(9):2378-89
17694575
J Exp Med. 2008 Sep 1;205(9):1975-81
18710931
Immunity. 2008 Nov 14;29(5):758-70
19006694
Immunol Rev. 2008 Jun;223:391-421
18613849
J Exp Med. 2001 Sep 3;194(5):629-44
11535631
Nat Med. 2008 Dec;14(12):1390-5
18997777
J Exp Med. 2007 Jan 22;204(1):191-201
17210729
Blood. 2004 Dec 1;104(12):3804-12
15292057
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13031-6
12242333
Blood. 2008 Feb 1;111(3):1013-20
17951529